Intevac Announces Fourth Quarter and Full Year 2016 Financial Results
Wed, February 1 2017
2016 Highlights
-
Significant improvements in performance compared to 2015:
- Revenues increased 7%, driven by our Thin-film Equipment growth initiatives and improved results in our core HDD (hard disk drive) business
- Gross margin improved 300bp; operating P&L improved by 13%
- Total orders up 25%, driven by a 76% increase in Thin-film Equipment orders
- Total backlog up 34%, with Thin-film Equipment backlog up 139%
- Orders for four new INTEVAC VERTEXTM systems – from two customers
- Orders for eight 200 Lean® systems
- Successful demonstrations of latest digital night-vision technology – expanding our Photonics revenue opportunity pipeline by 40%
-
Positive cash flow from operations of
$3 .8 million - Achieved objective to increase total balance of cash and investments year-over-year
“2016 marked an inflection point in the future revenue growth trajectory
of Intevac,” commented
“We also delivered continued improvement in our financial performance in 2016. We improved our gross margins, held SG&A flat, increased our strategic R&D investments by 16%, and significantly improved our operating performance compared to 2015. We won significant new orders in our Thin-film Equipment business, and grew backlog to levels not seen since 2010; in each of our served equipment markets. Given the momentum we have built in our strategic growth initiatives, we are on the path to profitability for 2017.”
($ Millions, except per share amounts) | Q4 2016 | Q4 2015 | ||||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||||
Net Revenues | $ | 29.0 | $ | 29.0 | $ | 16.4 | $ | 16.4 | ||||||||||
Operating Income (Loss) | $ | 2.9 | $ | 2.9 | $ | (2.3 | ) | $ | (2.2 | ) | ||||||||
Net Income (Loss) | $ | 2.8 | $ | 2.8 | $ | (2.5 | ) | $ | (2.4 | ) | ||||||||
Net Income (Loss) per Diluted Share | $ | 0.13 | $ | 0.13 | $ | (0.12 | ) | $ | (0.12 | ) | ||||||||
|
Year Ended | Year Ended | ||||||||||||||||
|
|
|||||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||||||
Net Revenues | $ | 80.1 | $ | 80.1 | $ | 75.2 | $ | 75.2 | ||||||||||
Operating Loss | $ | (7.6 | ) | $ | (7.7 | ) | $ | (8.7 | ) | $ | (8.8 | ) | ||||||
Net Loss | $ | (7.4 | ) | $ | (7.5 | ) | $ | (9.2 | ) | $ | (9.3 | ) | ||||||
Net Loss per Diluted Share | $ | (0.36 | ) | $ | (0.36 | ) | $ | (0.41 | ) | $ | (0.42 | ) | ||||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section. |
Fourth Quarter Fiscal 2016 Summary
Net income for the quarter was
Revenues were
Thin-film Equipment gross margin was 38.9% compared to 41.8 % in the fourth quarter of 2015 and 32.4% in the third quarter of 2016. The improvement from the third quarter of 2016 reflected higher revenues and improved factory absorption in the fourth quarter, and the lower-margin solar ion implant R&D tool included in revenues for the third quarter. The decline from the fourth quarter of 2015 reflected a higher mix of systems shipments versus higher-margin upgrades, offset in part by improved factory absorption.
Photonics gross margin was 45.5% compared to 39.6% in the fourth quarter of 2015 and 46.9% in the third quarter of 2016. The decline from the third quarter of 2016 was due to lower margins on technology development contracts. The improvement from the fourth quarter of 2015 was primarily due to higher margins on technology development contracts and lower inventory provisions. Consolidated gross margin was 41.1%, compared to 40.7% in the fourth quarter of 2015 and 37.7% in the third quarter of 2016.
Order backlog totaled
The Company ended the year with
Fiscal Year 2016 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 32.8%, compared to 32.4% in 2015. The improvement from 2015 reflected a higher level of revenue and improved factory absorption. Photonics gross margin was 44.6% compared to 37.9% in 2015, reflecting a higher mix of product sales versus lower-margin technology development contracts. Consolidated gross margin was 38.0% compared to 35.0% in 2015.
Total R&
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PST (4:30 p.m. EST). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
||||||||||||||||||
Three months ended |
|
Year ended |
||||||||||||||||
|
|
|
|
|||||||||||||||
Net revenues | ||||||||||||||||||
Thin-film Equipment | $ | 19,312 | $ | 8,308 | $ | 45,253 | $ | 39,622 | ||||||||||
Photonics | 9,670 | 8,090 | 34,871 | 35,538 | ||||||||||||||
Total net revenues | 28,982 | 16,398 | 80,124 | 75,160 | ||||||||||||||
Gross profit | 11,912 | 6,677 | 30,409 | 26,317 | ||||||||||||||
Gross margin | ||||||||||||||||||
Thin-film Equipment | 38.9 | % | 41.8 | % | 32.8 | % | 32.4 | % | ||||||||||
Photonics | 45.5 | % | 39.6 | % | 44.6 | % | 37.9 | % | ||||||||||
Consolidated | 41.1 | % | 40.7 | % | 38.0 | % | 35.0 | % | ||||||||||
Operating expenses | ||||||||||||||||||
Research and development | 3,937 | 4,150 | 18,156 | 15,661 | ||||||||||||||
Selling, general and administrative | 5,102 | 4,723 | 19,916 | 19,638 | ||||||||||||||
Acquisition-related1 | (10 | ) | 106 | (100 | ) | (244 | ) | |||||||||||
Total operating expenses | 9,029 | 8,979 | 37,972 | 35,055 | ||||||||||||||
Total operating income (loss) | 2,883 | (2,302 | ) | (7,563 | ) | (8,738 | ) | |||||||||||
Operating income (loss) | ||||||||||||||||||
Thin-film Equipment | 1,807 | (2,119 | ) | (8,309 | ) | (9,345 | ) | |||||||||||
Photonics | 2,157 | 1,146 | 5,813 | 5,206 | ||||||||||||||
Corporate | (1,081 | ) | (1,329 | ) | (5,067 | ) | (4,599 | ) | ||||||||||
Total operating income (loss) | 2,883 | (2,302 | ) | (7,563 | ) | (8,738 | ) | |||||||||||
Interest income and other income (expense), net | 190 | 39 | 373 | 127 | ||||||||||||||
Income (loss) before income taxes | 3,073 | (2,263 | ) | (7,190 | ) | (8,611 | ) | |||||||||||
Provision for income taxes | 238 | 263 | 251 | 555 | ||||||||||||||
Net income (loss) | $ | 2,835 | $ | (2,526 | ) | $ | (7,441 | ) | $ | (9,166 | ) | |||||||
Net income (loss) per share | ||||||||||||||||||
Basic | $ | 0.14 | $ | (0.12 | ) | $ | (0.36 | ) | $ | (0.41 | ) | |||||||
Diluted | $ | 0.13 | $ | (0.12 | ) | $ | (0.36 | ) | $ | (0.41 | ) | |||||||
Weighted average common shares outstanding | ||||||||||||||||||
Basic | 20,935 | 21,010 | 20,761 | 22,218 | ||||||||||||||
Diluted | 21,739 | 21,010 | 20,761 | 22,218 | ||||||||||||||
1Amounts for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
|
|||||||||
|
|
||||||||
(Unaudited) | (see Note) | ||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash, cash equivalents and short-term investments | $ | 44,645 | $ | 36,954 | |||||
Accounts receivable, net | 17,447 | 12,310 | |||||||
Inventories | 24,876 | 18,760 | |||||||
Prepaid expenses and other current assets |
1,768 | 1,712 | |||||||
Total current assets | 88,736 | 69,736 | |||||||
Long-term investments | 3,593 | 9,673 | |||||||
Restricted cash | 1,602 | 1,780 | |||||||
Property, plant and equipment, net | 11,237 | 11,921 | |||||||
Intangible assets, net | 2,258 | 3,112 | |||||||
Other long-term assets | 898 | 1,459 | |||||||
Total assets | $ | 108,324 | $ | 97,681 | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
Current liabilities | |||||||||
Accounts payable | $ | 5,323 | $ | 5,950 | |||||
Accrued payroll and related liabilities | 4,220 |
|
4,066 |
||||||
Other accrued liabilities | 17,011 | 5,632 | |||||||
Customer advances | 5,422 | 3,625 | |||||||
Total current liabilities | 31,976 | 19,273 | |||||||
Other long-term liabilities | 3,082 | 2,411 | |||||||
Stockholders’ equity | |||||||||
Common stock ( |
21 | 20 | |||||||
Additional paid-in capital | 171,314 | 166,514 | |||||||
|
(28,489 | ) | (28,489 | ) | |||||
Accumulated other comprehensive income | 321 | 412 | |||||||
Accumulated deficit | (69,901 | ) | (62,460 | ) | |||||
Total stockholders’ equity | 73,266 | 75,997 | |||||||
Total liabilities and stockholders’ equity | $ | 108,324 | $ | 97,681 | |||||
Note: Amounts as of |
|
||||||||||||||||||
Three months ended |
|
Year ended |
||||||||||||||||
|
|
|
|
|||||||||||||||
Non-GAAP Income (Loss) from Operations | ||||||||||||||||||
Reported operating income (loss) (GAAP basis) | $ | 2,883 | $ | (2,302 | ) | $ | (7,563 | ) | $ | (8,738 | ) | |||||||
Change in fair value of contingent consideration obligations1 | (10 | ) | 106 | (100 | ) | (244 | ) | |||||||||||
Restructuring charges2 | — | — | — | 148 | ||||||||||||||
Non-GAAP Operating Income (Loss) | $ | 2,873 | $ | (2,196 | ) | $ | (7,663 | ) | $ | (8,834 | ) | |||||||
Non-GAAP Net Income (Loss) | ||||||||||||||||||
Reported net income (loss) (GAAP basis) | $ | 2,835 | $ | (2,526 | ) | $ | (7,441 | ) | $ | (9,166 | ) | |||||||
Change in fair value of contingent consideration obligations1 | (10 | ) | 106 | (100 | ) | (244 | ) | |||||||||||
Restructuring charges2 | — | — | — | 148 | ||||||||||||||
Income tax effect of non-GAAP adjustments3 | — | — | — | — | ||||||||||||||
Non-GAAP Net Income (Loss) | $ | 2,825 | $ | (2,420 | ) | $ | (7,541 | ) | $ | (9,262 | ) | |||||||
Non-GAAP Net Income (Loss) Per Diluted Share | ||||||||||||||||||
Reported net income (loss) per diluted share (GAAP basis) | $ | 0.13 | $ | (0.12 | ) | $ | (0.36 | ) | $ | (0.41 | ) | |||||||
Change in fair value of contingent consideration obligations1 | — | 0.01 | — | (0.01 | ) | |||||||||||||
Restructuring charges2 | — | — | — | 0.01 | ||||||||||||||
Non-GAAP Net Income (Loss) Per Diluted Share | $ | 0.13 | $ | (0.12 | ) | $ | (0.36 | ) | $ | (0.42 | ) | |||||||
Weighted average number of diluted shares | 21,739 | 21,010 | 20,761 | 22,218 | ||||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
2Results include severance and other employee-related costs related to various restructuring programs. |
3The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20170201005482/en/
Chief Financial Officer
or
Investor Relations
Source: